Skip to main content

Advertisement

SpringerLink
Log in

HIV and the kidney

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Direct effects of HIV-1 infection on the kidney combine with immune and genetic factors, comorbidities, coinfections, and medication toxicities to induce a spectrum of kidney disorders in HIV disease. The most dramatic of these, HIV-associated nephropathy (HIVAN), emerges almost exclusively in persons of African descent and is associated with rapid progression to end-stage renal disease in the absence of antiretroviral therapy (ART). ART modifies the natural history of HIVAN, but the renal benefits of ART may not be limited to HIVAN. ART is often under prescribed or incorrectly dosed in persons with kidney disease. Vigilant attention to renal function and an understanding of the complex associations involving the kidneys are necessary for optimal care of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gardner LI, Holmberg SD, Moore J, et al.: Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care. J Acquir Immune Defic Syndr 2002, 29:69–75.

    PubMed  Google Scholar 

  2. Szczech LA, Hoover DR, Feldman JG, et al.: Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004, 39:1199–1206.

    Article  PubMed  Google Scholar 

  3. Wyatt CM, Arons RR, Klotman PE, et al.: Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006, 20:561–565.

    Article  PubMed  Google Scholar 

  4. Mulenga LB, Kruse G, Lakhi S, et al.: Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 2008, 22:1821–1827.

    Article  PubMed  Google Scholar 

  5. Wools-Kaloustian K, On G’or WO, Wafula S, et al.: The relationships between renal dysfunction and clinical outcomes in HIV-infected Kenyans not requiring immediate ART [abstract 741]. Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; February 8–11, 2009. Available at http://www.retroconference.org. Accessed February 2009.

  6. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1–S266.

  7. Odden MC, Scherzer R, Bacchetti P, et al.: Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 2007, 167:2213–2219.

    Article  CAS  PubMed  Google Scholar 

  8. Vrouenraets S, Garcia E, Brinkman K, et al.: A comparison between different GFR-estimations and [125I]-iothalamate, the gold standard for GFR-measurement, in HIV-infected patients on HAART [abstract 977b]. Programs and Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3–6, 2008. Available at http://www.retroconference.org. Accessed February 2009.

  9. Franceschini N, Napravnik S, Eron JJ Jr, et al.: Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int 2005, 67:1526–1531.

    Article  PubMed  Google Scholar 

  10. Salliot C, Guichard I, Daugas E, et al.: Acute kidney disease due to immune reconstitution inflammatory syndrome in an HIV-infected patient with tuberculosis. J Int Assoc Physicians AIDS Care (Chic Ill) 2008, 7:178–181.

    Article  Google Scholar 

  11. Mocroft A, Kirk O, Gatell J, et al.: Chronic renal failure among HIV-1-infected patients. AIDS 2007, 21:1119–1127.

    Article  PubMed  Google Scholar 

  12. Wyatt CM, Winston JA, Malvestutto CD, et al.: Chronic kidney disease in HIV infection: an urban epidemic. AIDS 2007, 21:2101–2103.

    Article  PubMed  Google Scholar 

  13. Lucas GM, Mehta SH, Atta MG, et al.: End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007, 21:2435–2443.

    Article  PubMed  Google Scholar 

  14. Lucas GM, Lau B, Atta MG, et al.: Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008, 197:1548–1557.

    Article  PubMed  Google Scholar 

  15. Reid A, Stohr W, Walker AS, et al.: Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008, 46:1271–1281.

    Article  PubMed  Google Scholar 

  16. Rey L, Viciana A, Ruiz P: Immunopathological characteristics of in situ T-cell subpopulations in human immunodeficiency virus-associated nephropathy. Hum Pathol 1995, 26:408–415.

    Article  CAS  PubMed  Google Scholar 

  17. Kopp JB, Smith MW, Nelson GW, et al.: MYH9 is a majoreffect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008, 40:1175–1184.

    Article  CAS  PubMed  Google Scholar 

  18. Kao WH, Klag MJ, Meoni LA, et al.: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008, 40:1185–1192.

    Article  CAS  PubMed  Google Scholar 

  19. Kiryluk K, Martino J, Gharavi AG: Genetic susceptibility, HIV infection, and the kidney. Clin J Am Soc Nephrol 2007, 2(Suppl 1):S25–S35.

    Article  CAS  PubMed  Google Scholar 

  20. Cohen SD, Kimmel PL: Immune complex renal disease and human immunodeficiency virus infection. Semin Nephrol 2008, 28:535–544.

    Article  PubMed  Google Scholar 

  21. de Silva TI, Post FA, Griffin MD, et al.: HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc 2007, 82:1103–1116.

    Article  PubMed  Google Scholar 

  22. Weiner NJ, Goodman JW, Kimmel PL: The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 2003, 63:1618–1631.

    Article  PubMed  Google Scholar 

  23. Fine DM, Fogo AB, Alpers CE: Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient. Semin Nephrol 2008, 28:545–555.

    Article  PubMed  Google Scholar 

  24. Szczech LA, Gupta SK, Habash R, et al.: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004, 66:1145–1152.

    Article  PubMed  Google Scholar 

  25. Han TM, Naicker S, Ramdial PK, et al.: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006, 69:2243–2250.

    Article  CAS  PubMed  Google Scholar 

  26. Bruggeman LA, Dikman S, Meng C, et al.: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997, 100:84–92.

    Article  CAS  PubMed  Google Scholar 

  27. Zhong J, Zuo Y, Ma J, et al.: Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005, 68:1048–1060.

    Article  CAS  PubMed  Google Scholar 

  28. Cohen AH, Sun NC, Shapshak P, et al.: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 1989, 2:125–128.

    CAS  PubMed  Google Scholar 

  29. Kimmel PL, Phillips TM, Ferreira-Centeno A, et al.: HIV-associated immune-mediated renal disease. Kidney Int 1993, 44:1327–1340.

    Article  CAS  PubMed  Google Scholar 

  30. Bruggeman LA, Ross MD, Tanji N, et al.: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000, 11:2079–2087.

    CAS  PubMed  Google Scholar 

  31. Marras D, Bruggeman LA, Gao F, et al.: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002, 8:522–526.

    Article  CAS  PubMed  Google Scholar 

  32. Husain M, D’Agati VD, He JC, et al.: HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005, 19:1975–1980.

    Article  CAS  PubMed  Google Scholar 

  33. Lu TC, He JC, Wang ZH, et al.: HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem 2008, 283:8173–8182.

    Article  CAS  PubMed  Google Scholar 

  34. Schwarz K, Simons M, Reiser J, et al.: Podocin, a raftassociated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001, 108:1621–1629.

    CAS  PubMed  Google Scholar 

  35. Sunamoto M, Husain M, He JC, et al.: Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int 2003, 64:1695–1701.

    Article  CAS  PubMed  Google Scholar 

  36. He JC, Husain M, Sunamoto M, et al.: Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 2004, 114:643–651.

    CAS  PubMed  Google Scholar 

  37. Martinka S, Bruggeman LA: Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy. Am J Physiol Renal Physiol 2006, 290:F657–F665.

    Article  CAS  PubMed  Google Scholar 

  38. Ross MJ, Martinka S, D’Agati VD, et al.: NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol 2005, 16:2403–2411.

    Article  CAS  PubMed  Google Scholar 

  39. Hayden MS, Ghosh S: Shared principles in NF-kappaB signaling. Cell 2008, 132:344–362.

    Article  CAS  PubMed  Google Scholar 

  40. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365–1371.

    Article  CAS  PubMed  Google Scholar 

  41. Baenziger S, Heikenwalder M, Johansen P, et al.: Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 2009, 113:377–388.

    Article  CAS  PubMed  Google Scholar 

  42. Mandl JN, Barry AP, Vanderford TH, et al.: Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008, 14:1077–1087.

    Article  CAS  PubMed  Google Scholar 

  43. Albaqumi M, Soos TJ, Barisoni L, et al.: Collapsing glomerulopathy. J Am Soc Nephrol 2006, 17:2854–2863.

    Article  CAS  PubMed  Google Scholar 

  44. Ross MJ, Fan C, Ross MD, et al.: HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 2006, 42:1–11.

    Article  CAS  PubMed  Google Scholar 

  45. O’Donnell MP, Chao CC, Gekker G, et al.: Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes. Kidney Int 1998, 53:593–597.

    Article  PubMed  Google Scholar 

  46. Kuller LH, Tracy R, Belloso W, et al.: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5:e203.

    Article  PubMed  Google Scholar 

  47. Herbein G, Khan KA: Is HIV infection a TNF receptor signalling-driven disease? Trends Immunol 2008, 29:61–67.

    Article  CAS  PubMed  Google Scholar 

  48. Lucas GM, Eustace JA, Sozio S, et al.: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004, 18:541–546.

    Article  PubMed  Google Scholar 

  49. Krawczyk CS, Holmberg SD, Moorman AC, et al.: Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004, 18:2171–2178.

    Article  PubMed  Google Scholar 

  50. El-Sadr WM, Lundgren JD, Neaton JD, et al.: CD4+ countguided interruption of antiretroviral treatment. N Engl J Med 2006, 355:2283–2296.

    Article  CAS  PubMed  Google Scholar 

  51. Mocroft A, Wyatt C, Szczech L, et al.: Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 2009, 23:71–82.

    Article  CAS  PubMed  Google Scholar 

  52. Beversluis D, Reynolds S, Kityo C, et al.: Greater renal function preservation is associated with continuous vs intermittent ART [abstract 742]. Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; February 8–11, 2009. Available at http://www.retroconference.org. Accessed February 2009.

  53. Kalayjian RC, Franceschini N, Gupta SK, et al.: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008, 22:481–487.

    Article  CAS  PubMed  Google Scholar 

  54. Peters PJ, Moore DM, Mermin J, et al.: Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008, 74:925–929.

    Article  CAS  PubMed  Google Scholar 

  55. Karras A, Lafaurie M, Furco A, et al.: Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 2003, 36:1070–1073.

    Article  PubMed  Google Scholar 

  56. Jones R, Stebbing J, Nelson M, et al.: Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. J Acquir Immune Defic Syndr 2004, 37:1489–1495.

    Article  CAS  PubMed  Google Scholar 

  57. Gallant JE, Winston JA, DeJesus E, et al.: The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients. AIDS 2008, 22:2155–2163.

    Article  CAS  PubMed  Google Scholar 

  58. Tourret J, Tostivint I, Tezenas Du Montcel S, et al.: Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis 2007, 45:779–784.

    Article  PubMed  Google Scholar 

  59. Winston J, Deray G, Hawkins T, et al.: Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis 2008, 47:1449–1457.

    Article  PubMed  Google Scholar 

  60. Gupta SK, Eustace JA, Winston JA, et al.: Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005, 40:1559–1585.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, MetroHealth Medical Center and Case Western Reserve University School of Medicine, 2500 MetroHealth Drive, Cleveland, OH, 44102, USA

    Robert C. Kalayjian

Authors
  1. Leslie A. Bruggeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles Bark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert C. Kalayjian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert C. Kalayjian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruggeman, L.A., Bark, C. & Kalayjian, R.C. HIV and the kidney. Curr Infect Dis Rep 11, 479–485 (2009). https://doi.org/10.1007/s11908-009-0069-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-009-0069-4

Keywords

Search

Navigation